Prof. Wuwei Yang 杨武威
Chief Physician, Professor
Department of Medical Oncology, Chinese PLA General Hospital (301 Hospital), First Medical Center, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive interventional therapy for malignant and benign conditions, including vascular intervention, ultrasound ablation (HIFU), argon-helium cryoablation, and microwave ablation. Focuses on liver, bone, soft tissue, pancreatic, renal, lung, and breast tumors, as well as uterine fibroids and adenomyosis.
Dr. Yang holds a Master of Clinical Medicine and has 25 years of clinical experience in oncology. Current roles include master’s supervisor at PLA General Hospital, Anhui Medical University, and Southern Medical University. Research focuses on minimally invasive interventional and comprehensive tumor therapy. Dr. Yang has led the development of diagnostic and treatment standards for focused ultrasound ablation and cryoablation.
Professional roles
- Chair, Ultrasound Therapy and Biological Effects Committee, Chinese Society of Ultrasound in Medicine and Engineering
- Vice Chair, Minimally Invasive Medicine Committee, Chinese Medical Doctor Association
- Vice Chair, Tumor Ultrasound Therapy Committee, China Anti-Cancer Association
- Standing Committee Member, Tumor Minimally Invasive Therapy Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Yang Wuwei). Papers usually list the name as Wuwei Yang or Yang W.
Selected publications
17 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Hyperthermia, 2026 (senior author): Safety, feasibility, and palliative benefit of HIFU combined with PD-1 inhibitors for elderly patients with advanced pancreatic cancer: a real-world retrospective study. PubMed 42552867
- Eur J Radiol, 2026 (senior author): Path forward: Cryoablation for colorectal liver metastases. PubMed 41926877
- J Cancer Res Ther, 2026 (senior author): Cryoablation for plantar alveolar soft part sarcoma: A case report. PubMed 42241177
- J Cancer Res Ther, 2025 (first author): Development of an evaluation index system for intelligent minimally invasive tumor ablation based on telemedicine. PubMed 40905878
- Sci Prog, 2025 (senior author): A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report. PubMed 40696842
- J Cancer Res Ther, 2021 (senior author): Survival analysis of patients with recurrent or metastatic soft tissue sarcoma who were treated by cryoablation: A real-world retrospective study. PubMed 35381747
- Thorac Cancer, 2021 (first author): Co-ablation versus cryoablation for the treatment of stage III-IV non-small cell lung cancer: A prospective, noninferiority, randomized, controlled trial (RCT). PubMed 33319493
- Oncologist, 2020 (senior author): Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report. PubMed 31848313
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion